BRL-42715

• Description:

  BRL-42715 is a potent inhibitor of a broad range of bacterial beta-lactamases (β-lactamase) [1].

• UNSPSC:

  12352005

• Target:

  Bacterial; Beta-lactamase

• Type:

  Reference compound

• Related Pathways:

  Anti-infection

• Applications:

  COVID-19-immunoregulation

• Field of Research:

  Infection

• Assay Protocol:

  https://www.medchemexpress.com/brl-42715.html

• Solubility:

  10 mM in DMSO

• Smiles:

  O=C (C (N1C/2=O) =CS[C@]1 ([H]) C2=C/C3=CN (C) N=N3) O[Na]

• Molecular Formula:

  C10H7N4NaO3S

• Molecular Weight:

  286.24

• References & Citations:

  [1]Coleman K, et al. In vitro evaluation of BRL 42715, a novel beta-lactamase inhibitor. Antimicrob Agents Chemother. 1989 Sep;33 (9) :1580-7.|[2]K Coleman, et al. In vitro evaluation of BRL 42715, a novel beta-lactamase inhibitor. Antimicrob Agents Chemother. 1989 Sep;33 (9) :1580-7.

• Shipping Conditions:

  Room temperature

• Scientific Category:

  Reference compound1

• Clinical Information:

  No Development Reported

• CAS Number:

  102209-75-6